Odyssey Therapeutics, Inc. (ODTX)

Odyssey Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Odyssey Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	-0.09	-0.20	-0.43
Debt / EBITDA Ratio	-0.26	-0.41	-0.49
Debt / FCF Ratio	-0.29	-0.45	-0.55
Quick Ratio	6.17	8.47	10.57
Return on Equity (ROE)	35.00%	47.94%	86.20%
Return on Assets (ROA)	-	-43.95%	-39.31%
Return on Capital (ROIC)	41.21%	63.65%	154.69%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).